RNA Analysis Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services, Instruments), By Technology (qPCR, Microarray, Sequencing), By Application, By End-use And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Information Analysis
                        1.2.2. Market Formulation & Data Visualization
                        1.2.3. Data Validation & Publishing
                    1.3. Research Assumptions
                    1.4. Information Procurement
                        1.4.1. Primary Research
                    1.5. Information or Data Analysis
                    1.6. Market Formulation & Validation
                    1.7. Market Model
                    1.8. Global Market: CAGR Calculation
                    1.9. Objectives
                        1.9.1. Objective 1:
                        1.9.2. Objective 2:
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing Demand for Transcriptomics in Cancer Personalized/Precision Medicine
                            3.2.1.2. Rising Diagnostic Utility Of Transcriptomics Technologies
                            3.2.1.3. Advent of Novel Approaches for Understanding Gene Expression at RNA Level
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Higher Cost of Research & Developments
                            3.2.2.2. High Costs Associated With Analysis Platforms
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
                    4.1. RNA Analysis Market: Product Movement Analysis
                    4.2. Instruments
                        4.2.1. Instruments Market, 2018 - 2030 (USD Million)
                    4.3. Kits & Reagents
                        4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
                        4.3.2. miRNA & siRNA
                            4.3.2.1. miRNA & siRNA Market, 2018 - 2030 (USD Million)
                        4.3.3. Reverse Transcriptases & RT-PCR
                            4.3.3.1. Reverse Transcriptases & RT-PCR Market, 2018 - 2030 (USD Million)
                        4.3.4. RNA Extraction & Purification
                            4.3.4.1. RNA Extraction & Purification Market, 2018 - 2030 (USD Million)
                        4.3.5. RNA Interference
                            4.3.5.1. RNA Interference Market, 2018 - 2030 (USD Million)
                        4.3.6. Others
                            4.3.6.1. Other Kits & Reagents Market, 2018 - 2030 (USD Million)
                    4.4. Services
                        4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
                    5.1. RNA Analysis Market: Technology Movement Analysis
                    5.2. Real Time-PCR (qPCR)
                        5.2.1. Real Time-PCR (qPCR) Market, 2018 - 2030 (USD Million)
                    5.3. Microarray
                        5.3.1. Microarray Market, 2018 - 2030 (USD Million)
                    5.4. Sequencing
                        5.4.1. Sequencing Market, 2018 - 2030 (USD Million)
                    5.5. Others
                        5.5.1. Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
                    6.1. RNA Analysis Market: Application Movement Analysis
                    6.2. Construction of RNA Expression Atlas
                        6.2.1. Construction of RNA Expression Atlas Market, 2018 - 2030 (USD Million)
                    6.3. Epigenetics
                        6.3.1. Epigenetics Market, 2018 - 2030 (USD Million)
                    6.4. Infectious Diseases & Pathogenesis
                        6.4.1. Infectious Diseases & Pathogenesis Market, 2018 - 2030 (USD Million)
                    6.5. Alternative RNA Splicing
                        6.5.1. Alternative RNA Splicing Market, 2018 - 2030 (USD Million)
                    6.6. RNA Structure & Molecular Dynamics
                        6.6.1. RNA Structure & Molecular Dynamics Market, 2018 - 2030 (USD Million)
                    6.7. Development & Delivery of RNA Therapeutics
                        6.7.1. Development & Delivery of RNA Therapeutics Market, 2018 - 2030 (USD Million)
                    6.8. Others
                        6.8.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
                    7.1. Government Institutes & Academic Centers
                        7.1.1. Government Institutes & Academic Centers Market, 2018 - 2030 (USD Million)
                    7.2. Pharmaceutical & Biotechnology Companies
                        7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
                    7.3. Hospitals & Clinics
                        7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
                    7.4. Contract Research Organizations (CROs)
                        7.4.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
                    8.1. RNA Analysis Market Share By Region, 2022 & 2030
                    8.2. North America
                        8.2.1. North America RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.2.2. U.S.
                            8.2.2.1. Key Country Dynamics
                            8.2.2.2. Target Disease Prevalence
                            8.2.2.3. Competitive Scenario
                            8.2.2.4. U.S. RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.2.3. Canada
                            8.2.3.1. Key Country Dynamics
                            8.2.3.2. Target Disease Prevalence
                            8.2.3.3. Competitive Scenario
                            8.2.3.4. Canada RNA Analysis Market, 2018 - 2030 (USD Million)
                    8.3. Europe
                        8.3.1. Europe RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.2. UK
                            8.3.2.1. Key Country Dynamics
                            8.3.2.2. Target Disease Prevalence
                            8.3.2.3. Competitive Scenario
                            8.3.2.4. UK RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.3. Germany
                            8.3.3.1. Key Country Dynamics
                            8.3.3.2. Target Disease Prevalence
                            8.3.3.3. Competitive Scenario
                            8.3.3.4. Germany RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.4. France
                            8.3.4.1. Key Country Dynamics
                            8.3.4.2. Target Disease Prevalence
                            8.3.4.3. Competitive Scenario
                            8.3.4.4. France RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.5. Italy
                            8.3.5.1. Key Country Dynamics
                            8.3.5.2. Target Disease Prevalence
                            8.3.5.3. Competitive Scenario
                            8.3.5.4. Italy RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.6. Spain
                            8.3.6.1. Key Country Dynamics
                            8.3.6.2. Target Disease Prevalence
                            8.3.6.3. Competitive Scenario
                            8.3.6.4. Spain RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.7. Denmark
                            8.3.7.1. Key Country Dynamics
                            8.3.7.2. Target Disease Prevalence
                            8.3.7.3. Competitive Scenario
                            8.3.7.4. Denmark RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.8. Sweden
                            8.3.8.1. Key Country Dynamics
                            8.3.8.2. Target Disease Prevalence
                            8.3.8.3. Competitive Scenario
                            8.3.8.4. Sweden RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.3.9. Norway
                            8.3.9.1. Key Country Dynamics
                            8.3.9.2. Target Disease Prevalence
                            8.3.9.3. Competitive Scenario
                            8.3.9.4. Norway RNA Analysis Market, 2018 - 2030 (USD Million)
                    8.4. Asia Pacific
                        8.4.1. Asia Pacific RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.2. Japan
                            8.4.2.1. Key Country Dynamics
                            8.4.2.2. Target Disease Prevalence
                            8.4.2.3. Competitive Scenario
                            8.4.2.4. Japan RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.3. China
                            8.4.3.1. Key Country Dynamics
                            8.4.3.2. Target Disease Prevalence
                            8.4.3.3. Competitive Scenario
                            8.4.3.4. China RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.4. India
                            8.4.4.1. Key Country Dynamics
                            8.4.4.2. Target Disease Prevalence
                            8.4.4.3. Competitive Scenario
                            8.4.4.4. India RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.5. Australia
                            8.4.5.1. Key Country Dynamics
                            8.4.5.2. Target Disease Prevalence
                            8.4.5.3. Competitive Scenario
                            8.4.5.4. Australia RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.6. Thailand
                            8.4.6.1. Key Country Dynamics
                            8.4.6.2. Target Disease Prevalence
                            8.4.6.3. Competitive Scenario
                            8.4.6.4. Thailand RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.4.7. South Korea
                            8.4.7.1. Key Country Dynamics
                            8.4.7.2. Target Disease Prevalence
                            8.4.7.3. Competitive Scenario
                            8.4.7.4. South Korea RNA Analysis Market, 2018 - 2030 (USD Million)
                    8.5. Latin America
                        8.5.1. Latin America RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.5.2. Brazil
                            8.5.2.1. Key Country Dynamics
                            8.5.2.2. Target Disease Prevalence
                            8.5.2.3. Competitive Scenario
                            8.5.2.4. Brazil RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.5.3. Mexico
                            8.5.3.1. Key Country Dynamics
                            8.5.3.2. Target Disease Prevalence
                            8.5.3.3. Competitive Scenario
                            8.5.3.4. Mexico RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.5.4. Argentina
                            8.5.4.1. Key Country Dynamics
                            8.5.4.2. Target Disease Prevalence
                            8.5.4.3. Competitive Scenario
                            8.5.4.4. Argentina RNA Analysis Market, 2018 - 2030 (USD Million)
                    8.6. MEA
                        8.6.1. MEA RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.6.2. South Africa
                            8.6.2.1. Key Country Dynamics
                            8.6.2.2. Target Disease Prevalence
                            8.6.2.3. Competitive Scenario
                            8.6.2.4. South Africa RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.6.3. Saudi Arabia
                            8.6.3.1. Key Country Dynamics
                            8.6.3.2. Target Disease Prevalence
                            8.6.3.3. Competitive Scenario
                            8.6.3.4. Saudi Arabia RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.6.4. UAE
                            8.6.4.1. Key Country Dynamics
                            8.6.4.2. Target Disease Prevalence
                            8.6.4.3. Competitive Scenario
                            8.6.4.4. UAE RNA Analysis Market, 2018 - 2030 (USD Million)
                        8.6.5. Kuwait
                            8.6.5.1. Key Country Dynamics
                            8.6.5.2. Target Disease Prevalence
                            8.6.5.3. Competitive Scenario
                            8.6.5.4. Kuwait RNA Analysis Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Share Analysis, 2022
                    9.4. Company Profiles/Listing
                        9.4.1. Agilent Technologies, Inc
                            9.4.1.1. Overview
                            9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.1.3. Product Benchmarking
                            9.4.1.4. Strategic Initiatives
                        9.4.2. F. Hoffmann-La Roche AG
                            9.4.2.1. Overview
                            9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.2.3. Product Benchmarking
                            9.4.2.4. Strategic Initiatives
                        9.4.3. Illumina, Inc.
                            9.4.3.1. Overview
                            9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.3.3. Product Benchmarking
                            9.4.3.4. Strategic Initiatives
                        9.4.4. QIAGEN
                            9.4.4.1. Overview
                            9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.4.3. Product Benchmarking
                            9.4.4.4. Strategic Initiatives
                        9.4.5. Thermo Fisher Scientific, Inc.
                            9.4.5.1. Overview
                            9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.5.3. Product Benchmarking
                            9.4.5.4. Strategic Initiatives
                        9.4.6. Eurofins Scientific
                            9.4.6.1. Overview
                            9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.6.3. Product Benchmarking
                            9.4.6.4. Strategic Initiatives
                        9.4.7. Merck KGaA
                            9.4.7.1. Overview
                            9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.7.3. Product Benchmarking
                            9.4.7.4. Strategic Initiatives
                        9.4.8. Bio-Rad Laboratories, Inc.
                            9.4.8.1. Overview
                            9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.8.3. Product Benchmarking
                            9.4.8.4. Strategic Initiatives
                        9.4.9. Pacific Bioscience of California, Inc.;
                            9.4.9.1. Overview
                            9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.9.3. Product Benchmarking
                            9.4.9.4. Strategic Initiatives
                        9.4.10. Affymetrix, Inc.
                            9.4.10.1. Overview
                            9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.10.3. Product Benchmarking
                            9.4.10.4. Strategic Initiatives
                        9.4.11. Danaher
                            9.4.11.1. Overview
                            9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.11.3. Product Benchmarking
                            9.4.11.4. Strategic Initiatives
                        9.4.12. Promega
                            9.4.12.1. Overview
                            9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.12.3. Product Benchmarking
                            9.4.12.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 Global RNA analysis market, by product, 2018 - 2030 (USD Million)
Table 3 Global RNA analysis market, by technology, 2018 - 2030 (USD Million)
Table 4 Global RNA analysis market, by application, 2018 - 2030 (USD Million)
Table 5 Global RNA analysis market, by end-use, 2018 - 2030 (USD Million)
Table 6 Global RNA analysis market, by region, 2018 - 2030 (USD Million)
Table 7 North America RNA analysis market by product, 2018 - 2030 (USD Million)
Table 8 North America RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 9 North America RNA analysis market by application, 2018 - 2030 (USD Million)
Table 10 North America RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 11 U.S. RNA analysis market by product, 2018 - 2030 (USD Million)
Table 12 U.S. RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 13 U.S. RNA analysis market by application, 2018 - 2030 (USD Million)
Table 14 U.S. RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 15 Canada RNA analysis market by product, 2018 - 2030 (USD Million)
Table 16 Canada RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 17 Canada RNA analysis market by application, 2018 - 2030 (USD Million)
Table 18 Canada RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 19 Europe RNA analysis market by product, 2018 - 2030 (USD Million)
Table 20 Europe RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 21 Europe RNA analysis market by application, 2018 - 2030 (USD Million)
Table 22 Europe RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 23 Germany RNA analysis market by product, 2018 - 2030 (USD Million)
Table 24 Germany RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 25 Germany RNA analysis market by application, 2018 - 2030 (USD Million)
Table 26 Germany RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 27 U.K. RNA analysis market by product, 2018 - 2030 (USD Million)
Table 28 U.K. RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 29 U.K. RNA analysis market by application, 2018 - 2030 (USD Million)
Table 30 U.K. RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 31 France RNA analysis market by product, 2018 - 2030 (USD Million)
Table 32 France RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 33 France RNA analysis market by application, 2018 - 2030 (USD Million)
Table 34 France RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 35 Italy RNA analysis market by product, 2018 - 2030 (USD Million)
Table 36 Italy RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 37 Italy RNA analysis market by application, 2018 - 2030 (USD Million)
Table 38 Italy RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 39 Spain RNA analysis market by product, 2018 - 2030 (USD Million)
Table 40 Spain RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 41 Spain RNA analysis market by application, 2018 - 2030 (USD Million)
Table 42 Spain RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 43 Denmark RNA analysis market by product, 2018 - 2030 (USD Million)
Table 44 Denmark RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 45 Denmark RNA analysis market by application, 2018 - 2030 (USD Million)
Table 46 Denmark RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 47 Sweden RNA analysis market by product, 2018 - 2030 (USD Million)
Table 48 Sweden RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 49 Sweden RNA analysis market by application, 2018 - 2030 (USD Million)
Table 50 Sweden RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 51 Norway RNA analysis market by product, 2018 - 2030 (USD Million)
Table 52 Norway RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 53 Norway RNA analysis market by application, 2018 - 2030 (USD Million)
Table 54 Norway RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific RNA analysis market by product, 2018 - 2030 (USD Million)
Table 56 Asia Pacific RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 57 Asia Pacific RNA analysis market by application, 2018 - 2030 (USD Million)
Table 58 Asia Pacific RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 59 China RNA analysis market by product, 2018 - 2030 (USD Million)
Table 60 China RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 61 China RNA analysis market by application, 2018 - 2030 (USD Million)
Table 62 China RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 63 Japan RNA analysis market by product, 2018 - 2030 (USD Million)
Table 64 Japan RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 65 Japan RNA analysis market by application, 2018 - 2030 (USD Million)
Table 66 Japan RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 67 India RNA analysis market by product, 2018 - 2030 (USD Million)
Table 68 India RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 69 India RNA analysis market by application, 2018 - 2030 (USD Million)
Table 70 India RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 71 Australia RNA analysis market by product, 2018 - 2030 (USD Million)
Table 72 Australia RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 73 Australia RNA analysis market by application, 2018 - 2030 (USD Million)
Table 74 Australia RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 75 Thailand RNA analysis market by product, 2018 - 2030 (USD Million)
Table 76 Thailand RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 77 Thailand RNA analysis market by application, 2018 - 2030 (USD Million)
Table 78 Thailand RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 79 South Korea RNA analysis market by product, 2018 - 2030 (USD Million)
Table 80 South Korea RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 81 South Korea RNA analysis market by application, 2018 - 2030 (USD Million)
Table 82 South Korea RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 83 Latin America RNA analysis market by product, 2018 - 2030 (USD Million)
Table 84 Latin America RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 85 Latin America RNA analysis market by application, 2018 - 2030 (USD Million)
Table 86 Latin America RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 87 Brazil RNA analysis market by product, 2018 - 2030 (USD Million)
Table 88 Brazil RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 89 Brazil RNA analysis market by application, 2018 - 2030 (USD Million)
Table 90 Brazil RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 91 Mexico RNA analysis market by product, 2018 - 2030 (USD Million)
Table 92 Mexico RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 93 Mexico RNA analysis market by application, 2018 - 2030 (USD Million)
Table 94 Mexico RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 95 Argentina RNA analysis market by product, 2018 - 2030 (USD Million)
Table 96 Argentina RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 97 Argentina RNA analysis market by application, 2018 - 2030 (USD Million)
Table 98 Argentina RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 99 MEA RNA analysis market by product, 2018 - 2030 (USD Million)
Table 100 MEA RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 101 MEA RNA analysis market by application, 2018 - 2030 (USD Million)
Table 102 MEA RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 103 South Africa RNA analysis market by product, 2018 - 2030 (USD Million)
Table 104 South Africa RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 105 South Africa RNA analysis market by application, 2018 - 2030 (USD Million)
Table 106 South Africa RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia RNA analysis market by product, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia RNA analysis market by application, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 111 UAE RNA analysis market by product, 2018 - 2030 (USD Million)
Table 112 UAE RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 113 UAE RNA analysis market by application, 2018 - 2030 (USD Million)
Table 114 UAE RNA analysis market by end-use, 2018 - 2030 (USD Million)
Table 115 Kuwait RNA analysis market by product, 2018 - 2030 (USD Million)
Table 116 Kuwait RNA analysis market by technology, 2018 - 2030 (USD Million)
Table 117 Kuwait RNA analysis market by application, 2018 - 2030 (USD Million)
Table 118 Kuwait RNA analysis market by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 RNA analysis market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 RNA analysis market: Products outlook and key takeaways
Fig. 15 RNA analysis market: Product movement analysis
Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 miRNA and siRNA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Reverse transcriptase & RT-PCR market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 RNA extraction & purification market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 RNA interference market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Others kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 RNA analysis market: Technology outlook and key takeaways
Fig. 25 RNA analysis market: Technology movement analysis
Fig. 26 Real time-PCR (qPCR) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 RNA analysis market: Application outlook and key takeaways
Fig. 31 RNA analysis Market: Application movement analysis
Fig. 32 Construction of RNA expression atlas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Infectious diseases and pathogenesis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Alternative RNA splicing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 RNA structure and molecular dynamics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Development and delivery of RNA therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Others applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 RNA analysis market: End-use outlook and key takeaways
Fig. 40 RNA analysis market: End-use movement analysis
Fig. 41 Government institutes & academic centers estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Pharmaceutical & biotechnology companies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hospitals & clinics estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Contract Research Organizations (CROs) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 RNA analysis market: Regional outlook and key takeaways
Fig. 46 RNA analysis market: Regional movement analysis
Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)